• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“拯救不列颠哥伦比亚省(SAVE BC):预防不列颠哥伦比亚省心血管事件研究”的设计与原理

The design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British Columbia.

作者信息

Brunham Liam R, Lynch Kelsey, English Amy, Sutherland Rory, Weng Jian, Cho Raymond, Wong Graham C, Anis Aslam H, Francis Gordon A, Khan Nadia A, McManus Bruce, Wood David, Walley Keith R, Leipsic Jonathon, Humphries Karin H, Hoens Alison, Krahn Andrew D, John Mancini G B, Pimstone Simon

机构信息

Department of Medicine, University of British Columbia, Vancouver, Canada.

Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada.

出版信息

Clin Cardiol. 2018 Jul;41(7):888-895. doi: 10.1002/clc.22959. Epub 2018 Jun 11.

DOI:10.1002/clc.22959
PMID:29635745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6490105/
Abstract

Atherosclerotic cardiovascular disease (ASCVD) is highly heritable, particularly when it occurs at a young age. The screening of individuals with premature ASCVD, although often recommended, is not routinely performed. Strategies to address this gap in care are essential. We designed the Study to Avoid CardioVascular Events in British Columbia (SAVE BC) as a prospective, observational study of individuals with a new diagnosis of very premature ASCVD (defined as age ≤ 50 years in males and age ≤ 55 years in females) and their first-degree relatives (FDRs) and spouses. FDRs and spouses will undergo screening for cardiovascular (CV) risk factors and subclinical ASCVD using a structured screening algorithm. All subjects will be followed longitudinally for ≥10 years. The overall goal of SAVE BC is to evaluate the yield of a structured screening program for identifying individuals at risk of premature ASCVD. The primary objectives of SAVE BC are to identify and follow index cases with very premature ASCVD and their FDRs and to determine the diagnostic yield of a structured screening program for these individuals. We will collect data on CV risk factors, medication use, CV events, and healthcare costs in these individuals. SAVE BC will provide insight regarding approaches to identify individuals at risk for premature ASCVD with implications for prevention and treatment in this population.

摘要

动脉粥样硬化性心血管疾病(ASCVD)具有高度遗传性,尤其是在年轻时发病。尽管经常有人建议对患有过早ASCVD的个体进行筛查,但这并非常规操作。解决这一护理缺口的策略至关重要。我们设计了不列颠哥伦比亚省避免心血管事件研究(SAVE BC),作为一项前瞻性观察性研究,研究对象为新诊断出患有极早发性ASCVD(定义为男性年龄≤50岁,女性年龄≤55岁)的个体及其一级亲属(FDR)和配偶。FDR和配偶将使用结构化筛查算法接受心血管(CV)危险因素和亚临床ASCVD的筛查。所有受试者将进行≥10年的纵向随访。SAVE BC的总体目标是评估结构化筛查项目在识别有过早ASCVD风险个体方面的成效。SAVE BC的主要目标是识别并跟踪患有极早发性ASCVD的索引病例及其FDR,并确定针对这些个体的结构化筛查项目的诊断成效。我们将收集这些个体的CV危险因素、用药情况、CV事件和医疗费用数据。SAVE BC将为识别有过早ASCVD风险个体的方法提供见解,对该人群的预防和治疗具有启示意义。

相似文献

1
The design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British Columbia.“拯救不列颠哥伦比亚省(SAVE BC):预防不列颠哥伦比亚省心血管事件研究”的设计与原理
Clin Cardiol. 2018 Jul;41(7):888-895. doi: 10.1002/clc.22959. Epub 2018 Jun 11.
2
The 2013 ACC/AHA risk score and subclinical cardiac remodeling and dysfunction: Complementary in cardiovascular disease prediction.2013 ACC/AHA 风险评分与亚临床心脏重构和功能障碍:在心血管疾病预测中的互补作用。
Int J Cardiol. 2019 Dec 15;297:67-74. doi: 10.1016/j.ijcard.2019.09.061. Epub 2019 Oct 9.
3
Cardiovascular Risk Factors Among First-Degree Relatives of Patients with Premature Cardiovascular Disease in Malta. Baseline Findings from the CRISO Project.马耳他早发性心血管疾病患者一级亲属中的心血管危险因素。CRISO项目的基线研究结果。
Vasc Health Risk Manag. 2024 Apr 9;20:167-176. doi: 10.2147/VHRM.S449672. eCollection 2024.
4
Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study.早发动脉粥样硬化性心血管疾病与更高的癌症风险相关:一项行为危险因素监测系统研究。
Eur J Prev Cardiol. 2022 Mar 25;29(3):493-501. doi: 10.1093/eurjpc/zwab084.
5
Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.家族性高胆固醇血症患者的心血管疾病预防:PCSK9 抑制剂的作用。
Eur J Prev Cardiol. 2017 Sep;24(13):1383-1401. doi: 10.1177/2047487317717346. Epub 2017 Jun 23.
6
Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.采用他汀类药物进行一级预防:ACC/AHA 基于风险的方法与基于试验的方法指导他汀类药物治疗。
J Am Coll Cardiol. 2015 Dec 22;66(24):2699-2709. doi: 10.1016/j.jacc.2015.09.089.
7
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).预测家族性高胆固醇血症中的心血管事件:SAFEHEART 登记研究(西班牙家族性高胆固醇血症队列研究)。
Circulation. 2017 May 30;135(22):2133-2144. doi: 10.1161/CIRCULATIONAHA.116.024541. Epub 2017 Mar 8.
8
Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.比较 ACC/AHA 指南、成人治疗专家组 III 指南和欧洲心脏病学会指南在欧洲队列中用于心血管疾病预防的应用。
JAMA. 2014 Apr 9;311(14):1416-23. doi: 10.1001/jama.2014.2632.
9
Men's health in northern British Columbia: analysis and reporting of early intervention screening program data related to cardiovascular health.不列颠哥伦比亚省北部男性健康:与心血管健康相关的早期干预筛查项目数据分析与报告
Glob J Health Sci. 2012 Jun 7;4(4):90-106. doi: 10.5539/gjhs.v4n4p90.
10
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA 血脂管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组的报告
Circulation. 2019 Jun 18;139(25):e1144-e1161. doi: 10.1161/CIR.0000000000000626. Epub 2018 Nov 10.

引用本文的文献

1
Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease.对发生过早冠状动脉疾病的患者进行预防性降脂治疗及其与医疗保健的相互作用。
JACC Adv. 2024 Oct 16;4(1):101316. doi: 10.1016/j.jacadv.2024.101316. eCollection 2025 Jan.
2
Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular disease.早发性心血管疾病患者一级亲属的心血管风险与亚临床动脉粥样硬化
Am J Prev Cardiol. 2024 Jul 4;19:100704. doi: 10.1016/j.ajpc.2024.100704. eCollection 2024 Sep.
3
The Importance of Nontraditional and Sex-Specific Risk Factors in Young Women With Vasomotor Nonobstructive vs Obstructive Coronary Syndromes.非传统及性别特异性危险因素在患有血管舒缩性非阻塞性与阻塞性冠状动脉综合征的年轻女性中的重要性
CJC Open. 2023 Sep 9;6(2Part B):279-291. doi: 10.1016/j.cjco.2023.08.012. eCollection 2024 Feb.
4
Identification and treatment of those most at risk for premature atherosclerotic cardiovascular disease: We just cannot seem to get it right.识别和治疗那些动脉粥样硬化性心血管疾病过早发病风险最高的人群:我们似乎就是做不对。
Am J Prev Cardiol. 2020 Jul 15;2:100040. doi: 10.1016/j.ajpc.2020.100040. eCollection 2020 Jun.
5
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation.用于早发性动脉粥样硬化性冠状动脉疾病一级预防的降脂治疗:资格、应用、目标达成及起始治疗的预测因素。
Am J Prev Cardiol. 2020 Jul 17;2:100036. doi: 10.1016/j.ajpc.2020.100036. eCollection 2020 Jun.
6
Priorities for Services in Young Patients With Atherosclerotic Cardiovascular Disease and Their Family Members: An Exploratory Mixed-Methods Study.年轻动脉粥样硬化性心血管疾病患者及其家庭成员的服务重点:一项探索性混合方法研究。
CJC Open. 2019 Mar 6;1(3):107-114. doi: 10.1016/j.cjco.2019.02.003. eCollection 2019 May.
7
Premature Atherosclerotic Cardiovascular Disease: Trends in Incidence, Risk Factors, and Sex-Related Differences, 2000 to 2016.早发动脉粥样硬化性心血管疾病:2000 年至 2016 年的发病率、危险因素和性别差异趋势。
J Am Heart Assoc. 2019 Jul 16;8(14):e012178. doi: 10.1161/JAHA.119.012178. Epub 2019 Jul 8.

本文引用的文献

1
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.年轻人心肌梗死后的心血管风险和他汀类药物适用性:Partners YOUNG-MI 注册研究。
J Am Coll Cardiol. 2018 Jan 23;71(3):292-302. doi: 10.1016/j.jacc.2017.11.007. Epub 2017 Nov 12.
2
Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry.年轻心肌梗死患者研究:YOUNG-MI注册研究的设计与原理
Clin Cardiol. 2017 Nov;40(11):955-961. doi: 10.1002/clc.22774. Epub 2017 Aug 14.
3
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.加拿大高血压学会 2017 年成人高血压诊断、风险评估、预防和治疗指南。
Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10.
4
Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement from the Society of Cardiovascular Computed Tomography.无症状患者冠状动脉钙化积分的临床指征:心血管计算机断层成像学会的专家共识声明。
J Cardiovasc Comput Tomogr. 2017 Mar-Apr;11(2):157-168. doi: 10.1016/j.jcct.2017.02.010. Epub 2017 Feb 24.
5
Coronary Plaque Burden and Adverse Plaque Characteristics Are Increased in Healthy Relatives of Patients With Early Onset Coronary Artery Disease.健康的早发冠心病患者的亲属中,冠状动脉斑块负担和不良斑块特征增加。
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1128-1135. doi: 10.1016/j.jcmg.2016.10.014. Epub 2017 Jan 18.
6
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.《2016年加拿大心血管学会成人血脂异常管理预防心血管疾病指南》
Can J Cardiol. 2016 Nov;32(11):1263-1282. doi: 10.1016/j.cjca.2016.07.510. Epub 2016 Jul 25.
7
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南:欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组(由10个学会的代表和特邀专家组成)由欧洲心血管预防与康复协会(EACPR)特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
8
Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction: The VIRGO Study.急性心肌梗死年轻患者中心脏危险因素、感知风险以及医疗服务提供者关于风险与风险修正讨论的性别差异:VIRGO研究
J Am Coll Cardiol. 2015 Nov 3;66(18):1949-1957. doi: 10.1016/j.jacc.2015.08.859.
9
Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial.下一步冠心病一级预防:ECAD 试验的原理和设计。
J Am Coll Cardiol. 2015 Oct 20;66(16):1828-1836. doi: 10.1016/j.jacc.2015.08.857.
10
A detailed family history of myocardial infarction and risk of myocardial infarction--a nationwide cohort study.心肌梗死的详细家族史与心肌梗死风险——一项全国性队列研究
PLoS One. 2015 May 26;10(5):e0125896. doi: 10.1371/journal.pone.0125896. eCollection 2015.